Episode 2 The Startup Way

Harry Glorikian is an executive leader with extensive experience in the life sciences and healthcare sectors. He's also a general partner at Scientia Ventures VC firm. In this episode with Harry we discuss:

1. His venture capital journey and his prior experience in the healthcare and life sciences industry.
2. Evaluating investment opportunities in the biotech sector and the importance of the team in a startup's potential success.
3. The success of Scientia Ventures IPOs and the notable example of Royalty Pharma.
4. The challenges and nuances of investing in biotech.
5. The traditional and low-tech nature of the venture capital industry.
6. Exciting trends in biotech and health tech, including AI applications, remote clinical trials, gene editing, immuno-oncology, and data analytics.
7. Emerging biotech hubs and factors that contribute to a geography's potential for success in biotech startups.
8. Lessons learned from investment failures and the importance of active listening and sharing experiences.
9. The impact of working in the biotech and health tech industry on personal health and wellness.
10. The prevalence of pseudoscientific advice in the health and wellness space and the need for evidence-based approaches.